magnetic resonance spectroscopy (MRS);
liver;
spectroscopy;
lymphoma;
phosphorus metabolism;
D O I:
10.1055/s-2007-1015493
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
P-31-MR spectroscopy of the human liver - spectral hints on hepatic lymphoma infiltration. Purpose: To evaluate whether phosphorus magnetic resonance spectroscopy (P-31-MRS) enables a non-invasive detection of liver involvement in systemic diseases like Hodgkin's lymphoma. Materials and methods: Using a clinical 1.5 Tesla whole-body MR system image-guided localised phosphorus MR spectra from the anatomically defined volumes of interests were measured. A combination of surface coil, adiabatic excitation pulse and modified image-selected in vivo spectroscopy (ISIS)-sequence was applied. The spectroscopy data were evaluated quantitatively with a time-domain fit programme using non-linear optimisation algorithms to quantify peak areas. After establishment of the ex; amination protocol, 22 healthy volunteers and 13 patients with suspected lymphoma infiltration of the liver were examined. Results: Liver spectra of patients suffering from lymphoma infiltration differed significantly from spectra of persons with normal liver: 1. The peak area ratio of phosphomonoesters (PME) to beta-NTP was elevated in all patients with histologically confirmed liver lymphoma. 2. Patients suffering from Hodgkin's disease with specific or unspecific liver infiltration (n=7) could be differentiated from patients without liver involvement. In case of infiltrated liver, the peak area ratio PME to beta-NTP was increased, and the pH value was shifted to lower values. Unambiguous differentiation between non-specific (n=3) and specific (n=4) infiltration of the liver was not possible. 3. In patients after cytostatic treatment (n=3), an increase of the peak area ratio of inorganic phosphate to beta-NTP was observed. Conclusion: Our preliminary results indicate that P-31-MRS can yield pointers to liver involvement in patients with systemic diseases such as Hodgkin's disease, which may be hardly detected by imaging methods.
机构:
Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Med Univ Vienna, MR Ctr Excellence, Vienna, Austria
Vienna Univ Technol, Fac Phys, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Niess, Fabian
Fiedler, Georg B.
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Med Univ Vienna, MR Ctr Excellence, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Fiedler, Georg B.
Schmid, Albrecht I.
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Med Univ Vienna, MR Ctr Excellence, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Schmid, Albrecht I.
Goluch, Sigrun
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Med Univ Vienna, MR Ctr Excellence, Vienna, Austria
Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Goluch, Sigrun
Kriegl, Roberta
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Med Univ Vienna, MR Ctr Excellence, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Kriegl, Roberta
Wolzt, Michael
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Dept Clin Pharmacol, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Wolzt, Michael
Moser, Ewald
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Med Univ Vienna, MR Ctr Excellence, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Moser, Ewald
Meyerspeer, Martin
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
Med Univ Vienna, MR Ctr Excellence, Vienna, AustriaMed Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria